These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 4089809

  • 1. Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig.
    Handley DA, Lee ML, Saunders RN.
    Thromb Haemost; 1985 Dec 17; 54(4):756-9. PubMed ID: 4089809
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of dose and route effects of platelet activating factor-induced extravasation in the guinea pig.
    Handley DA, Van Valen RG, Melden MK, Saunders RN.
    Thromb Haemost; 1984 Aug 31; 52(1):34-6. PubMed ID: 6495262
    [Abstract] [Full Text] [Related]

  • 3. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB, Li CL, Lam MH, Shen TY.
    Lab Invest; 1985 Jun 31; 52(6):617-30. PubMed ID: 3925239
    [Abstract] [Full Text] [Related]

  • 4. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
    Issekutz AC, Szpejda M.
    Lab Invest; 1986 Mar 31; 54(3):275-81. PubMed ID: 3951199
    [Abstract] [Full Text] [Related]

  • 5. Evidence for distinct systemic extravasation effects of platelet activating factor, leukotrienes B4, C4, D4 and histamine in the guinea pig.
    Handley DA, Farley C, Deacon RW, Saunders RN.
    Prostaglandins Leukot Med; 1986 Mar 31; 21(3):269-77. PubMed ID: 3010331
    [Abstract] [Full Text] [Related]

  • 6. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J.
    J Pharmacol Exp Ther; 1997 Jan 31; 280(1):114-21. PubMed ID: 8996188
    [Abstract] [Full Text] [Related]

  • 7. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N, Murakami-Uchida M, Koike H, Natsume Y, Morooka S.
    Arzneimittelforschung; 1994 Mar 31; 44(3):317-22. PubMed ID: 8192697
    [Abstract] [Full Text] [Related]

  • 8. The effect of platelet-activating factor (PAF), histamine, and ethanol on vascular permeability of the guinea pig conjunctiva.
    Stock EL, Roth SI, Kim ED, Walsh MK, Thamman R.
    Invest Ophthalmol Vis Sci; 1990 May 31; 31(5):987-92. PubMed ID: 2335460
    [Abstract] [Full Text] [Related]

  • 9. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412.
    Handley DA, Van Valen RG, Melden MK, Houlihan WJ, Saunders RN.
    J Pharmacol Exp Ther; 1988 Nov 31; 247(2):617-23. PubMed ID: 3183958
    [Abstract] [Full Text] [Related]

  • 10. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE, Brooks J, Burton JL, Archer CB.
    Clin Exp Dermatol; 1996 Jan 31; 21(1):33-7. PubMed ID: 8689766
    [Abstract] [Full Text] [Related]

  • 11. Platelet activating factor-induced microvascular permeability increases in the cat hindlimb.
    Lu Z, Wolf MB.
    Circ Shock; 1993 Sep 31; 41(1):8-18. PubMed ID: 8403248
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factor.
    Yamada T, Tomioka K, Saito M, Horie M, Mase T, Hara H, Nagaoka H.
    Arch Int Pharmacodyn Ther; 1990 Sep 31; 308():123-36. PubMed ID: 2099131
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441.
    Handley DA, Tomesch JC, Saunders RN.
    Thromb Haemost; 1986 Aug 20; 56(1):40-4. PubMed ID: 3775689
    [Abstract] [Full Text] [Related]

  • 14. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B.
    Arzneimittelforschung; 1995 May 20; 45(5):559-68. PubMed ID: 7541995
    [Abstract] [Full Text] [Related]

  • 15. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD, Mikulaschek AW.
    Circ Shock; 1986 May 20; 20(3):193-203. PubMed ID: 3802423
    [Abstract] [Full Text] [Related]

  • 16. Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis.
    Brkovic A, Sirois MG.
    J Cell Biochem; 2007 Feb 15; 100(3):727-37. PubMed ID: 17115409
    [Abstract] [Full Text] [Related]

  • 17. Contribution of platelet activating factor (PAF) in histamine-induced model of nasal allergy in rats.
    Akagi M, Kanoh R, Fukuishi N, Tachibana M, Akagi R.
    Arerugi; 1995 Mar 15; 44(3 Pt 1):182-8. PubMed ID: 7646374
    [Abstract] [Full Text] [Related]

  • 18. Acute microcirculatory effects of platelet-activating factor.
    Durán WN, Dillon PK.
    J Lipid Mediat; 1990 Mar 15; 2 Suppl():S215-27. PubMed ID: 2133284
    [Abstract] [Full Text] [Related]

  • 19. Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms.
    Shimada T, Hirose T, Matsumoto I, Aikawa T.
    J Endocrinol; 2005 Feb 15; 184(2):381-91. PubMed ID: 15684346
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological studies of platelet-activating factor (PAF)-induced augmentation of response to histamine in guinea-pigs.
    Sakurai T, Yamaguchi S, Iwama T, Nagai H.
    Prostaglandins Leukot Essent Fatty Acids; 1994 Aug 15; 51(2):95-9. PubMed ID: 7972272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.